4
Changes in Ownership
CYTOKINETICS INC Filed Acc 0001127602-23-015541
Director sold 4,166 shares at $37.77 ($157,350)
- Director acquired 4,166 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
HENDERSON JOHN T · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-15 | Exercise or conversion : show line 1 in the form 10b5-1 | +4,166 | $6.78 | $28,245 | 29,586 | D |
| 2023-05-15 | Sale : show line 2 in the form 10b5-1 | −4,166 | $37.77 | $157,350 | 25,420 | D |
| Open-market sales · 4,166 sh · avg $37.77 · $157,350 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-15 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (Right to Buy) | −4,166 | 0 | D |
Loading xslF345X04/form4.xml…